Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bolt Biotherapeutics (BOLT) Gains from Sales and Divestitures (2022 - 2024)

Bolt Biotherapeutics (BOLT) has disclosed Gains from Sales and Divestitures for 3 consecutive years, with $41713.0 as the latest value for Q4 2024.

  • Quarterly Gains from Sales and Divestitures fell 28.12% to $41713.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $41713.0 through Dec 2024, down 28.12% year-over-year, with the annual reading at $41713.0 for FY2024, 28.12% down from the prior year.
  • Gains from Sales and Divestitures hit $41713.0 in Q4 2024 for Bolt Biotherapeutics, down from $58034.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $80533.0 in Q4 2022 to a low of $41713.0 in Q4 2024.
  • Historically, Gains from Sales and Divestitures has averaged $60093.3 across 3 years, with a median of $58034.0 in 2023.
  • Biggest five-year swings in Gains from Sales and Divestitures: decreased 27.94% in 2023 and later fell 28.12% in 2024.
  • Year by year, Gains from Sales and Divestitures stood at $80533.0 in 2022, then fell by 27.94% to $58034.0 in 2023, then fell by 28.12% to $41713.0 in 2024.
  • Business Quant data shows Gains from Sales and Divestitures for BOLT at $41713.0 in Q4 2024, $58034.0 in Q4 2023, and $80533.0 in Q4 2022.